NCT01990560View on ClinicalTrials.gov

Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Mild Hypercortisolism
Interventions
DRUG

Mifepristone

All patients in the study will receive daily Mifepristone for 6 months and primary and secondary outcomes will be assessed before and after the 6 month treatment period

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT01990560 - Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism | Biotech Hunter | Biotech Hunter